Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
Phase 1 Completed
39 enrolled
AMPLIFY-201
Phase 1 Completed
25 enrolled 15 charts
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
Phase 1 Completed
38 enrolled
Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer
Phase 1 Completed
9 enrolled
CEDAR
Phase 1 Completed
12 enrolled 13 charts
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Phase 1 Completed
9 enrolled
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers
Phase 1 Completed
129 enrolled 32 charts
A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer
Phase 1 Completed
15 enrolled
RAPIDO-TRACT
Phase 1 Completed
30 enrolled
Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery
Phase 1 Completed
26 enrolled
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Phase 1 Completed
Vaccine Therapy in Treating Patients With Metastatic Cancer
Phase 1 Completed
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Phase 1 Completed
117 enrolled
Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer
Phase 1 Completed
19 enrolled
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Phase 1 Completed
19 enrolled
AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
Phase 1 Completed
50 enrolled
AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer
Phase 1 Completed
31 enrolled
AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
Phase 1 Completed
26 enrolled
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
Phase 1 Completed
14 enrolled
CATRIPCA
Phase 1 Completed
54 enrolled
TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery
Phase 1 Completed
7 enrolled
Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
Phase 1 Completed
21 enrolled
Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma
Phase 1 Completed
20 enrolled
AlloMem
Phase 1 Completed
10 enrolled
A Study of PDR001 in Combination With CJM112, EGF816, IlarisĀ® (Canakinumab) or MekinistĀ® (Trametinib)
Phase 1 Completed
283 enrolled
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
Phase 1 Completed
53 enrolled
PRAER 1
Phase 1 Completed
29 enrolled
Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer
Phase 1 Completed
14 enrolled
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer
Phase 1 Completed
52 enrolled
Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer
Phase 1 Completed
22 enrolled 5 charts
Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer
Phase 1 Completed
13 enrolled 8 charts
Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer
Phase 1 Completed
29 enrolled
A Study of ARRY-438162 (MEK162) in Patients With Advanced Cancer
Phase 1 Completed
93 enrolled
A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma
Phase 1 Completed
15 enrolled
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
Phase 1 Completed
79 enrolled
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
Phase 1 Completed
66 enrolled
Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal Cancer
Phase 1 Completed
9 enrolled
Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
Phase 1 Completed
17 enrolled
Midostaurin (PKC412) for Locally Advanced Rectal Cancer
Phase 1 Completed
19 enrolled
PILLAR II
Phase 1 Completed
147 enrolled 14 charts
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Phase 1 Completed
30 enrolled
Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer
Phase 1 Completed
16 enrolled
MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer
Phase 1 Completed
26 enrolled
Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
Phase 1 Completed
1 enrolled
Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer
Phase 1 Completed
12 enrolled
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Phase 1 Completed
7 enrolled
Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer
Phase 1 Completed
17 enrolled
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
Phase 1 Completed
38 enrolled
Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer
Phase 1 Completed
5 enrolled